Pharmacokinetics (PK) studies how the body absorbs, distributes, metabolizes, and eliminates drugs, while pharmacodynamics (PD) examines the biochemical and physiological effects of drugs and their mechanisms of action. Together, PK/PD modeling is essential for determining optimal dosing regimens, predicting therapeutic outcomes, and minimizing toxicity. These principles form the foundation for drug development, clinical trials, and personalized therapy. Modern research focuses on integrating PK/PD data with pharmacogenomics to improve patient outcomes and address variability in drug response. Understanding PK and PD helps bridge laboratory findings with clinical applications for more precise and effective treatments.
Subtracts:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
